Latest News

Attune Medical Major Milestones: Including ensoETM in Cardiac Ablation Procedures Published Study and $4 Mil Convertible Note Closing

Dr. Mark Gallagher (St. George’s University Hospital, London UK) evaluated the use of the ensoETM in cardiac ablation procedures to ascertain whether using the esophageal space for temperature management could have the potential to decrease collateral thermal injury related to radio-frequency (RF) ablation for the treatment of atrial fibrillation.

Signia Introduces World’s First ‘Face Mask Mode’ for Hearing Devices: Improves Audibility for Those Communicating with Someone Wearing a Face Covering & No More Lip Reading

“The hearing challenges presented by face masks became obvious pretty quickly into the pandemic, so Signia developed the first-of-its-kind Face Mask Mode to help those with hearing loss better communicate in this new reality,” said Tish Ramirez, Au.D. of Signia. “When this setting is activated, the hearing aids optimally capture the sound of the speech signals, enabling the words to sound clearer and reducing any background noise to help the wearer understand what is being said.” 

Modulim Announces CE Mark of Clarifi Imaging System for Microvascular Assessment

Modulim can now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.

Genius AI Detection Receives FDA Clearance

Hologic notes the new technology which the company has now made commercially available represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius 3D Mammography exam.

Medela Announces NEW Pump In Style® Breast Pump with First-of-Its-Kind MaxFlow™ Technology

Medela announced the launch of the NEW Pump In Style with MaxFlow Technology double electric, personal-use breast pump in the U.S. and Canada. Featuring a hospital-performance, a closed system and intuitive control panel, Pump In Style combine the trusted performance moms expect from Medela with exclusive new unique technology and modern design.

“Parents today are busy, and even more so in a COVID-19 quarantined world. They balance jobs, childcare, potential homeschooling, and many other responsibilities, and these hardworking parents deserve a simple product that makes their lives easier,” said Melissa Gonzales, executive vice president of the Americas for Medela. “Redefining the breast pump that has supported millions of moms for nearly 25 years, during National Breastfeeding Month in the U.S., is an exciting milestone for Medela and an opportunity to honor moms with a highly effective, high performing and easy-to-use breast pump that works as hard as they do. During these difficult economic times, we wanted to introduce how we’ve reimagined the #1 breast pump chosen by moms and recommended by doctors** to support the breastfeeding families who need to access a high-quality breast pump through insurance, WIC and our retail partners.”

The Hardworking Pump for the Hardworking Mom

The Pump In Style Breast Pump with MaxFlow Technology is designed for moms who pump several times a day and need a highly effective breast pump to maintain their supply. Whether at home or at the office, running errands or enjoying family time, the NEW Pump In Style combines Medela’s deep knowledge and years of research to deliver hospital performance, an easy-to-use interface, comfort, and reassurance.

  • Performance: Innovative vacuum mechanism combines Medela’s research-based 2-Phase Expression® technology with a NEW MaxFlow technology, generating a vacuum with micro-vibrations to increase and optimize milk flow. A clinical pilot study compared MaxFlow technology with standard breast pump technology, revealing that MaxFlow removes a higher percentage of available milk faster than other breast pumps, a significant benefit for moms seeking to build and maintain their milk supply
  • Easy-to-Use Interface: Intuitive controls allow for simple pump operation and easy experience finding Maximum Comfort Vacuum® level. With fewer parts and large openings, it is also easier to clean compared to the previous version
  • Comfort: Two sizes of PersonalFit Flex™ breast shields with soft rim and oval shape for better fit and effective, yet comfortable pumping. The flex shields are another award-winning innovation added to this pump designed to help mom extract 11.8 percent more milk faster
  • Reassurance: Closed system prevents milk from entering the Y-tubing and pump motor, providing confidence in hygiene and quality of expressed milk. The new tube design eliminates tangling issues and simplifies the connection for double or single pumping

To ensure that all moms have access to continue feeding their babies with breast milk for longer, the new Pump In Style with MaxFlow Technology will be available through insurance plans beginning in September. Medela’s new Pump In Style with Max Flow will be available through major distributors that provide breast pumps through insurance, including Aeroflow Breastpumps, Byram Healthcare, Edgepark, and Medline @ Home; additional breast pump distributors will come online in October and November. Families who qualify for the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) will be able to access Pump In Style with MaxFlow technology in October.

The NEW Pump In Style with MaxFlow Technology retails for U.S. $199.99 to $249.99 SRP. It is available now for U.S. shoppers online at Amazon, Target.com, Walmart.com, BuyBuyBaby.com and in-store at Target, and it will be available in Buy Buy Baby Stores in October and at Walmart in November. For Canadian shoppers, the Pump In Style will be available for purchase beginning August 28 on Amazon.ca, Walmart.ca, BabiesRUs.ca and BuyBuyBaby.com, for $375 CDN.

 

Latest Posts

Fusion Antibodies and Queen’s University Belfast Awarded a £453,000 Grant from Invest Northern Ireland

The two organisations will use the funds to accelerate the discovery of novel therapeutic and diagnostic antibodies with validated anti-infective properties against COVID-19. Building on strong scientific knowhow, a new antibody development platform will be created that will help realise the vision of producing a breakthrough therapeutic that directly targets SARS-CoV-2.

Attune Medical Major Milestones: Including ensoETM in Cardiac Ablation Procedures Published Study and $4 Mil Convertible Note Closing

Dr. Mark Gallagher (St. George’s University Hospital, London UK) evaluated the use of the ensoETM in cardiac ablation procedures to ascertain whether using the esophageal space for temperature management could have the potential to decrease collateral thermal injury related to radio-frequency (RF) ablation for the treatment of atrial fibrillation.

Signia Introduces World’s First ‘Face Mask Mode’ for Hearing Devices: Improves Audibility for Those Communicating with Someone Wearing a Face Covering & No More Lip Reading

“The hearing challenges presented by face masks became obvious pretty quickly into the pandemic, so Signia developed the first-of-its-kind Face Mask Mode to help those with hearing loss better communicate in this new reality,” said Tish Ramirez, Au.D. of Signia. “When this setting is activated, the hearing aids optimally capture the sound of the speech signals, enabling the words to sound clearer and reducing any background noise to help the wearer understand what is being said.” 

Kayentis, a global provider of digital data capture systems for clinical trials, today announces it has raised €7M (approx. $8.3M) in growth capital.

Kayentis is active in the global electronic Clinical Outcome Assessment (eCOA) market, which is expected to reach $2.6 billion by 2027. Market growth in eCOA – a method of capturing outcomes data electronically in clinical trials – is driven by the clinical trials industry.

Don't Miss

New England Biolabs® Introduces NEBNext® Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set for Customizable RNA Depletion

This technology has been superb for eliminating the ribosomal RNA for a range of custom projects, including tracking novel viruses in mosquitoes, longitudinal profiling for astronauts, and host-pathogen interactions in COVID samples.

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

"FDA approval of the INTERCEPT Blood System for Cryoprecipitation is an important step forward in our mission to establish pathogen reduction as the standard of care for transfused blood components globally," said William ‘Obi’ Greenman, Cerus’ president and chief executive officer.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials. 

Stoke Therapeutics Announces Proposed Public Offering

November 18, 2020 Stoke Therapeutics, Inc., a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein...